agilon health, inc. Earnings Per Share (Basic)
agilon health, inc. (AGL) reported Earnings Per Share (Basic) of $1.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- agilon health, inc. earnings per share, basic for the quarter ending 2026-06-30 was $1.07.
- agilon health, inc. earnings per share, basic for the quarter ending 2026-03-31 was $2.95, a 304.11% increase year-over-year.
- agilon health, inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.46.
- agilon health, inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.27.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.07 10-Q · filed 2026-08-05 | $4.02 10-Q · filed 2026-08-05 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | $2.95 10-Q · filed 2026-05-06 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-02-25 |
| 2025-09-30 | -$0.27 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$6.31 10-Q · filed 2026-08-05 | -$5.58 10-Q · filed 2026-08-05 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | $0.73 10-Q · filed 2026-05-06 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-05-06 |
| 2024-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-02-25 |
| 2024-09-30 | -$0.29 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.36 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.38 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-02-25 |
| 2024-06-30 | -$0.07 derived: net income ÷ weighted average shares · filed 2025-08-04 | -$0.09 derived: net income ÷ weighted average shares · filed 2025-08-04 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-02-25 |
| 2024-03-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-02-25 |
| 2023-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-02-25 |
| 2023-09-30 | -$0.08 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.12 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.08 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.22 derived: net income ÷ weighted average shares · filed 2025-02-25 |
| 2023-06-30 | -$0.04 derived: net income ÷ weighted average shares · filed 2024-08-06 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-08-06 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$0.21 derived: net income ÷ weighted average shares · filed 2025-02-25 |
| 2023-03-31 | $0.04 derived: net income ÷ weighted average shares · filed 2024-05-07 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$0.17 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$0.22 derived: net income ÷ weighted average shares · filed 2025-02-25 |
| 2022-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$0.21 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-02-25 |
| 2022-09-30 | -$0.07 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$0.12 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$0.26 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-06-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2023-08-03 | -$0.05 derived: net income ÷ weighted average shares · filed 2023-08-03 | -$0.19 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.28 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-03-31 | $0.00 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.00 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2021-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.01 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.09 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2021-09-30 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.87 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.96 derived: net income ÷ weighted average shares · filed 2022-11-03 | |
| 2021-06-30 | -$0.79 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$0.89 derived: net income ÷ weighted average shares · filed 2022-08-04 | ||
| 2021-03-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2022-05-05 | |||
| 2020-12-31 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |